Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023380 (
lethargy
)
5,697
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The feasibility of water channel gene delivery to kidney tubules and microvessels was evaluated by delivery of an adenovirus encoding aquaporin 1 (
AQP1
-Ad5) to transgenic
AQP1
null mice. In wild-type mice,
AQP1
is expressed in kidney proximal tubule, thin descending limb of Henle, and descending vasa recta, where urine osmolality (Uosm) increases from 1000-1500 mOsm (before) to 2500-3500 mOsm after 36 hr of water deprivation. Uosm in
AQP1
null mice remains nearly fixed at 650-750 mOsm.
AQP1
-Ad5 (with a CMV promoter) was generated and purified. Infection of CHO cells gave strong uniform
AQP1
expression with plasma membrane localization and eightfold increased water permeability over noninfected cells.
AQP1
-Ad5 was delivered to 20 to 25-g
AQP1
null mice by tail vein infusion (0-10(10) PFU). At 3-7 days,
AQP1
protein expression was strongest in liver (approximately 20 microg of
AQP1
protein per liver) and next strongest in kidney, with expression in proximal tubule apical and basolateral membranes, and renal microvessels. Functional analysis showed increased water permeability in apical membrane vesicles from proximal tubule.
AQP1
expression was not detected in glomerulus, limb of Henle, or collecting duct. In water-deprived null mice receiving 5 x 10(9) PFU of
AQP1
-Ad5, Uosm increased by up to 510 mOsm (mean increase, 225 +/- 24 mOsm; n = 33 mice). Whereas the control null mice became
lethargic
and lost 34.2 +/- 0.6% body weight, the virus-treated mice remained relatively active and lost 32.3 +/- 0.7% body weight. Viral DNA and
AQP1
transcript were detected in kidney and liver of null mice up to 17 weeks after virus infusion; partial correction of the urinary concentrating defect persisted for 3-5 weeks. These results demonstrate partial functional correction of a urinary concentrating defect by adenoviral delivery of the
AQP1
gene.
...
PMID:Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene delivery. 1072 35